Plunkett Research Online: Allergy Therapeutics PLC

ALLERGY THERAPEUTICS PLC (AGYTF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Allergy Therapeutics PLC is involved in the development, manufacture, marketing and sale of pharmaceutical immunotherapy products, with a specific focus on allergy vaccines. The company sells a wide range of aluminum-free allergy vaccines and diagnostics, with the majority of sales arising from all.....



Allergy Therapeutics PLC
Ticker: AGYTF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 44 1903844700
Fax: 44 1903844726
Address: Dominion Way
Worthing, West Sussex BN14 8SA United Kingdom

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Contacts Description
Manuel Llobet CEO/Director
Nicolas Wykeman CFO/Director
See More
Allergy Therapeutics PLC is involved in the development, manufacture, marketing and sale of pharmaceutical immunotherapy products, with a specific focus on allergy vaccines. The company sells a wide range of aluminum-free allergy vaccines and diagnostics, with the majority of sales arising from all.....See More See More

Auditor: Grant Thornton UK LLP
Legal Advisor: Cooley LLP
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015 2014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (GBP) Bonus (GBP)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors:

Allergy Therapeutics offers employees a pension scheme, life assurance and private health care coverage.